ATE222789T1 - Verfahren zur transdermalen verabreichung von medikamenten - Google Patents

Verfahren zur transdermalen verabreichung von medikamenten

Info

Publication number: ATE222789T1
Authority: AT; Austria
Prior art keywords: voltage; medications; transdermal administration; calcitonin; minutes
Prior art date: 1995-03-17

Application number

AT96104194T

Other languages

English (en)

Inventor

Katsumi Iga

Shigeo Yanai

Keiichiro Okabe

Masaki Itoh

Original Assignee

Hisamitsu Pharmaceutical Co

Advance Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-17

Filing date

1996-03-15

Publication date

2002-09-15

1996-03-15 Application filed by Hisamitsu Pharmaceutical Co, Advance Co Ltd filed Critical Hisamitsu Pharmaceutical Co

2002-09-15 Application granted granted Critical

2002-09-15 Publication of ATE222789T1 publication Critical patent/ATE222789T1/de

Links

229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
102000055006 Calcitonin Human genes 0.000 abstract 2
108060001064 Calcitonin Proteins 0.000 abstract 2
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 2
229960004015 calcitonin Drugs 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/0436—Material of the electrode
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Electrotherapy Devices (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT96104194T 1995-03-17 1996-03-15 Verfahren zur transdermalen verabreichung von medikamenten ATE222789T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP8629095		1995-03-17

Publications (1)

Publication Number	Publication Date
ATE222789T1 true ATE222789T1 (de)	2002-09-15

Family

ID=13882714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96104194T ATE222789T1 (de)	1995-03-17	1996-03-15	Verfahren zur transdermalen verabreichung von medikamenten

Country Status (5)

Country	Link
US (1)	US5700481A (de)
EP (1)	EP0732121B1 (de)
AT (1)	ATE222789T1 (de)
CA (1)	CA2171910A1 (de)
DE (1)	DE69623155T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5735810A (en) *	1996-06-14	1998-04-07	Becton Dickinson And Company	Device for the iontophoretic administration of bisphosphonates
US6775569B2 (en) *	1997-11-05	2004-08-10	Hisamitsu Pharmaceutical Co., Inc.	Electroporation device for in vivo delivery of therapeutic agents
EP0950407B1 (de)	1998-04-14	2002-09-04	Hisamitsu Pharmaceutical Co., Inc.	Die Verwendung eines GP IIb/IIIa Antagonisten für die Herstellung eines Medikamentes geeignet zur transdermalen Applikation mittels Iontophorese
US6406455B1 (en)	1998-12-18	2002-06-18	Biovalve Technologies, Inc.	Injection devices
JP2002537031A (ja)	1999-02-18	2002-11-05	バイオバルブテクノロジーズインコーポレイテッド	電気活性な細孔
US6591133B1 (en)	2000-11-27	2003-07-08	Microlin Llc	Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices
US6571125B2 (en) *	2001-02-12	2003-05-27	Medtronic, Inc.	Drug delivery device
US7349733B2 (en) *	2001-11-02	2008-03-25	Ceramatel, Inc.	Iontophoretic drug delivery systems
US6775570B2 (en)	2002-02-04	2004-08-10	Ceramatec, Inc.	Iontophoretic treatment device
US7047069B2 (en)	2002-02-04	2006-05-16	Ceramatec, Inc.	Iontophoretic fluid delivery device
US7458982B2 (en) *	2002-10-04	2008-12-02	Photokinetix, Inc.	Photokinetic delivery of biologically active substances using pulsed incoherent light
US20070025869A1 (en) *	2005-07-15	2007-02-01	Gordon John H	Fluid Delivery Device
NZ596498A (en) *	2006-04-13	2013-05-31	Nupathe Inc	Transdermal methods and systems for the delivery of anti-migraine compounds
US8214030B2 (en) *	2006-09-06	2012-07-03	Encore Medical Asset Corporation	Iontophoresis apparatus and method
US20080147186A1 (en) *	2006-12-14	2008-06-19	Joshi Ashok V	Electrochemical Implant For Delivering Beneficial Agents
US20080177219A1 (en) *	2007-01-23	2008-07-24	Joshi Ashok V	Method for Iontophoretic Fluid Delivery
US8197844B2 (en)	2007-06-08	2012-06-12	Activatek, Inc.	Active electrode for transdermal medicament administration
US8862223B2 (en)	2008-01-18	2014-10-14	Activatek, Inc.	Active transdermal medicament patch and circuit board for same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5250022A (en) *	1990-09-25	1993-10-05	Rutgers, The State University Of New Jersey	Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
JP2585002B2 (ja) *	1987-07-02	1997-02-26	日東電工株式会社	経皮薬物投与用の電圧印加装置
JPS6411565A (en) *	1987-07-03	1989-01-17	Nitto Denko Corp	Drug admistrating method by iontophoresis
JP2834157B2 (ja) *	1988-11-04	1998-12-09	久光製薬株式会社	イオントフォレーシス用デバイス
US5167616A (en) *	1989-12-14	1992-12-01	Alza Corporation	Iontophoretic delivery method
US5207752A (en) *	1990-03-30	1993-05-04	Alza Corporation	Iontophoretic drug delivery system with two-stage delivery profile
USH1160H (en) *	1990-11-26	1993-04-06		Iontophoretic delivery of peptides
DE69429603T2 (de) *	1993-09-22	2002-08-14	Hisamitsu Pharmaceutical Co., Inc.	Iontophoresematrix

1996
- 1996-03-12 US US08/614,376 patent/US5700481A/en not_active Expired - Fee Related
- 1996-03-15 EP EP96104194A patent/EP0732121B1/de not_active Expired - Lifetime
- 1996-03-15 AT AT96104194T patent/ATE222789T1/de not_active IP Right Cessation
- 1996-03-15 DE DE69623155T patent/DE69623155T2/de not_active Expired - Fee Related
- 1996-03-15 CA CA002171910A patent/CA2171910A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0732121A1 (de)	1996-09-18
US5700481A (en)	1997-12-23
DE69623155D1 (de)	2002-10-02
DE69623155T2 (de)	2003-04-17
CA2171910A1 (en)	1996-09-18
EP0732121B1 (de)	2002-08-28

Similar Documents

Publication	Publication Date	Title
ATE222789T1 (de)	2002-09-15	Verfahren zur transdermalen verabreichung von medikamenten
ATE114486T1 (de)	1994-12-15	Verfahren und vorrichtung zur iontophoretischen abgabe von medikamenten.
ATE96678T1 (de)	1993-11-15	Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
ATE165983T1 (de)	1998-05-15	Reduktion von hautirritationen und hautwiderstand während einer iontophoresebehandlung
WO1991008795A3 (en)	1991-07-25	Improved iontophoretic delivery method
ATE179339T1 (de)	1999-05-15	Elektrische stimulierung zur behandlung von inkontinenz und anderen neuromuskularerkrankungen
FI915878A0 (fi)	1991-12-13	Menetelmä ja laite elektrolyyttiliuoksen käsittelemiseksi sähköisesti
TW368420B (en)	1999-09-01	Apparatus and method for transdermal molecular delivery by applying sufficient amplitude of electric field to induce migration of molecules through pores in the stratum corneum
ATE224753T1 (de)	2002-10-15	Vorrichtung zur verabreichung von medikamenten durch elektrotransport
IE790030L (en)	1980-04-18	Iontophoretic treatment.
NL191698B (nl)	1995-12-01	Werkwijze voor het detecteren en behandelen van abnormale hartfrequenties met een implanteerbare inrichting en inrichting voor het toepassen van deze werkwijze.
PT96021A (pt)	1991-09-13	Metodo de tratamento de doencas utilizando potenciadores de fluxo transdermico tais como acido e 1-dodecilazacicloheptan-2-ona em combinacao com iontoforese na administracao topica de agentes farmaceuticos
MY105566A (en)	1994-10-31	Method of and apparatus for applying voltage to electrostatic chuck
DE69830178D1 (de)	2005-06-16	Wirstoffmischung in vagal-induzierter asystolie
ATE514373T1 (de)	2011-07-15	Minimalinvasives system und verfahren zur überwachung von analytenkonzentrationen
DE69736981D1 (de)	2007-01-04	In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
DE3580060D1 (de)	1990-11-15	Verfahren und vorrichtung zum auflegen von baendern.
HUP9904023A2 (hu)	2000-03-28	Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
ATE108322T1 (de)	1994-07-15	Reduzierende kosmetische zusammensetzung zur haardauerwellung auf basis eines esters der thioglycolsäure und eines n-acyl(c2-c4)- cysteamines sowie verfahren zu deren anwendung.
ATE189417T1 (de)	2000-02-15	Verfahren zur abtötung von mikroorganismen und/oder mineralisierung organischer substanzen im boden und/oder im grundwasser
DE69532477D1 (de)	2004-02-26	Zusammensetzung, vorrichtung und verfahren zur verbesserten elektrotransport-wirkstoffabgabe
AU7429394A (en)	1995-04-13	Nerve stimulation apparatus and method
DE58903968D1 (de)	1993-05-06	Verfahren und vorrichtung zur kunststoffbeschichtung von strangprofilen.
ATE201997T1 (de)	2001-06-15	Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
ATE131733T1 (de)	1996-01-15	Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese

Legal Events

Date	Code	Title	Description
2003-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties